Melanoma Brain Tumors Treated with CyberKnife
Part of Brain & nervous system, Cancer, Skin clinical trials.
This trial tests CyberKnife, a precise radiation treatment, for melanoma that has spread to the brain. It may help you if you haven't had whole-brain radiation or brain surgery before.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have melanoma that has spread to your brain (confirmed by MRI or CT scan).
- Your brain tumors can be treated with a precise form of radiation called stereotactic radiotherapy (CyberKnife).
- You can have other treatments like immunotherapy or targeted therapy at the same time or at different times.
- The melanoma has not spread to the thin lining around your brain and spinal cord (leptomeningeal disease).
- You have not had whole-brain radiation or surgery to remove brain metastases in the past.
- Your melanoma started in the skin (not in the eye or other areas).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new approach for people with a single large brain tumor that has spread from another cancer. You would receive a short, focused dose of radiation (stereotactic radiosurgery) in small, separate treatments, followed by surgery to remove the tumor. The goal is to see if this combination works better than the usual treatment.
This trial looks at how well (and how much) CyberKnife radiation works for people with multiple brain metastases. It may help your care team understand the best way to treat several brain spots safely.
This trial studies whether giving the immunotherapy drug nivolumab together with targeted brain radiation (not whole-brain radiation) helps people with melanoma that has spread to the brain. It aims to improve brain control while keeping side effects manageable.
This trial tests a combination of a drug that stops blood vessel growth (bevacizumab), immunotherapy, and focused radiation to treat melanoma that has spread to the brain and is causing symptoms. The goal is to see if this approach shrinks tumors and improves outcomes.
This Phase 3 study tests whether immunotherapy or targeted medicine, with or without a one-time focused brain radiation procedure, can control brain metastases from melanoma or non-small cell lung cancer. It mainly enrolls people who have no (or minimal) brain symptoms and are newly diagnosed in the brain (except for certain recent brain surgery).
This study tests a targeted radiation treatment for brain tumors that have spread from lung cancer and may not have responded to other treatments. The goal is to see if this precise radiation approach can shrink these tumors and improve survival with fewer side effects.
Hear when a new Melanoma (Skin Cancer) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.